Free Trial

NewAmsterdam Pharma (NAMS) SEC Filings & 10K Form

NewAmsterdam Pharma logo
$20.03 0.00 (0.00%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$20.02 -0.01 (-0.02%)
As of 05/2/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent NewAmsterdam Pharma SEC Filings

DateFilerForm TypeView
04/21/2025
4:41 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:34 PM
Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/17/2025
4:36 PM
Gulfo Adele M. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:41 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
4:06 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
4:36 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:18 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:20 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:24 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:29 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
5:19 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
5:00 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
3:27 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:29 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
03/10/2025
3:52 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B3
03/06/2025
4:32 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
5:10 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:54 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
4:06 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/26/2025
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
4:24 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G/A
01/31/2025
4:00 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:25 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
4:16 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
4:09 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
3:52 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Somaiya Mayur Ian (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
3:26 PM
NAP PoolCo B.V. (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
7:27 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
4:58 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:03 PM
Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:08 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
5:09 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2025
4:57 PM
LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:21 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:08 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
4:10 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Virtually Limitless Energy? (Ad)

A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.

One company’s discovery could change power forever
01/07/2025
4:12 PM
JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:29 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/06/2025
4:57 PM
Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:48 PM
Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:51 PM
JONES WILLIAM A JR (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:53 PM
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:54 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:56 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
3:25 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
4:35 PM
BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
4:05 PM
Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:00 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/17/2024
9:28 AM
Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
12/16/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2024
7:28 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
5:33 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/12/2024
3:15 PM
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Forbion Growth Management B.V. (Reporting)
Forbion Growth Opportunities Fund I Cooperatief U.A. (Reporting)
Forbion IV Management B.V. (Reporting)
ForGrowth NAP B.V. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
6:57 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3MEF
12/10/2024
3:48 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
12/10/2024
6:24 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2024
6:07 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:29 PM
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13D/A
11/14/2024
4:46 PM
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/06/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2024
7:02 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 20-F/A
10/18/2024
3:51 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
4:01 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:23 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
4:12 PM
Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
4:22 PM
Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
3:20 PM
AMGEN INC (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
Form SC 13G/A
08/22/2024
3:30 PM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
08/09/2024
4:21 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 424B5
08/09/2024
4:23 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
4:24 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form POS AM
08/07/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
7:30 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
3:30 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2024
3:30 PM
Joustra Wouter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/19/2024
3:31 PM
McKenna Mark C. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
7:10 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2024
11:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form EFFECT
07/03/2024
3:34 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the May 1st funding window clos
07/03/2024
3:31 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/24/2024
7:30 AM
Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
7:12 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
3:15 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:18 PM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form ARS
05/09/2024
7:00 AM
NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NAMS) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners